I wonder if joint replacements are too mundane to appeal to the academic side of medicineMaybe these academic centers being referral centers for more complex cases would be unlikely to see early disease to begin with and therefore sized up the lack of volume to justify effort for unicompartment disease.On top of that, most orthopedics are skeptical of durability of a unicompartment repair.......and it's very expensive mistake if not durable since it costs 2/3 rds of a total knee. The durability issue transcends just the alignment issue because implant materials are not as familiar as would be the big national companies.Anyway.....these were the issues I believe that stunted academia getting on board.Which of course gets back to the issue of MAKO's radical strategic shift to include total knees and total hips.........they dramatically expanded their addressable market........the ONLY reason I am still interested in the stock........and of course that ISRG is gonna buy them and put the RIO in the DaVinci ;)
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat